- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, November 10, 2023
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article in Becker’s Payer Issues referenced a study to be published in the November 2023 issue of The American Journal of Managed Care® (AJMC®). The study, “Medicare Advantage in Rural Areas: Implications for Hospital Sustainability,” found that Medicare Advantage use increased from 2008 to 2019 and greater hospital sustainability was associated with that increase.
A study titled “All-Payer Value-Based Contracting in Organizations With Medicare ACOs,” to be published in the November 2023 issue of AJMC, was referenced in a RevCycle Intelligence article. The study found there has been growth of non-Medicare value-based contracts and contracts with downside risk based on a 2022 survey of accountable care organizations.
An article from Becker’s Health IT referenced a video interview published on AJMC.com, the website of AJMC. The interview, “Dr Sara Horst Shares Current, Future Improvements to VUMC’s Digital Health,” featured Sara Horst, MD, MPH, FACG, discussing changes in digital health systems at Vanderbilt University Medical Center, both past and upcoming.
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
On the Path to Greater Precision in Treating Multiple Myeloma
August 18th 2025Past efforts to collect data and to understand the relationship between minimal residual disease and outcomes will allow help researchers in multiple myeloma develop a new generation of targeted therapies, decide when treatment can be stopped, and possibly screen populations for the disease.
Read More
